ATE420653T1 - Von tryptophanyl-trna-synthetase stammende polypeptide zur regulierung der angiogenese - Google Patents

Von tryptophanyl-trna-synthetase stammende polypeptide zur regulierung der angiogenese

Info

Publication number
ATE420653T1
ATE420653T1 AT02802957T AT02802957T ATE420653T1 AT E420653 T1 ATE420653 T1 AT E420653T1 AT 02802957 T AT02802957 T AT 02802957T AT 02802957 T AT02802957 T AT 02802957T AT E420653 T1 ATE420653 T1 AT E420653T1
Authority
AT
Austria
Prior art keywords
polypeptide
tryptophanyl
sequence
encodes
trna synthetase
Prior art date
Application number
AT02802957T
Other languages
English (en)
Inventor
Paul Schimmel
Keisuke Wakasugi
Martin Friedlander
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE420653T1 publication Critical patent/ATE420653T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
    • C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
    • C12Y601/01002—Tryptophan-tRNA ligase (6.1.1.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02802957T 2001-02-23 2002-02-22 Von tryptophanyl-trna-synthetase stammende polypeptide zur regulierung der angiogenese ATE420653T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27095101P 2001-02-23 2001-02-23

Publications (1)

Publication Number Publication Date
ATE420653T1 true ATE420653T1 (de) 2009-01-15

Family

ID=23033541

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02802957T ATE420653T1 (de) 2001-02-23 2002-02-22 Von tryptophanyl-trna-synthetase stammende polypeptide zur regulierung der angiogenese

Country Status (18)

Country Link
US (1) US20030017564A1 (de)
EP (2) EP1377305B1 (de)
JP (2) JP4361734B2 (de)
KR (1) KR100869914B1 (de)
CN (1) CN100486992C (de)
AT (1) ATE420653T1 (de)
AU (2) AU2002306558B2 (de)
BR (1) BR0207449A (de)
CA (1) CA2438273C (de)
DE (1) DE60230860D1 (de)
ES (1) ES2318063T3 (de)
IL (3) IL157558A0 (de)
MX (1) MXPA03007586A (de)
NZ (1) NZ528193A (de)
PL (1) PL208008B1 (de)
RU (1) RU2297425C2 (de)
WO (1) WO2002067970A1 (de)
ZA (1) ZA200307383B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903189B2 (en) * 2001-03-21 2005-06-07 The Scripps Research Institute Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
US20060104962A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
CN1307300C (zh) * 2002-07-25 2007-03-28 斯克里普斯研究学院 造血干细胞和治疗新生血管性眼部疾病的方法
US7838290B2 (en) * 2002-07-25 2010-11-23 The Scripps Research Institute Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
US20060104963A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
MXPA06014092A (es) * 2004-06-04 2007-03-15 Scripps Research Inst Composiciones y metodos para el tratamiento de enfermedades neovasculares.
US20060078556A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Antibodies and epitopes specific to tRNA synthetase fragments
US20060079473A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Multi-unit complexes and uses thereof
US20060078886A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Business methods for modulating angiogenesis
US20060079672A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Kits for modulating angiogenesis
US20060024286A1 (en) * 2004-08-02 2006-02-02 Paul Glidden Variants of tRNA synthetase fragments and uses thereof
US20060078553A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Diverse multi-unit complexes including a tRNA synthetase fragment
US8282921B2 (en) 2004-08-02 2012-10-09 Paul Glidden tRNA synthetase fragments
US20060079441A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Methods of modulating angiogenesis
US20060024288A1 (en) * 2004-08-02 2006-02-02 Pfizer Inc. tRNA synthetase fragments
US20060079472A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Methods for treating angiogenesis
US20060079474A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Analogs of tRNA synthetase fragments and uses thereof
US20060079673A1 (en) * 2004-08-02 2006-04-13 Paul Glidden Polynucleotides encoding tRNA synthetase fragments and uses thereof
DE102004054835A1 (de) * 2004-11-12 2006-05-24 VACUTEC Hochvakuum- & Präzisionstechnik GmbH Verfahren zur Herstellung einer Elektrode bzw. mehrpoligen Elektrodenanordnung sowie mehrpolige Elektrodenanordnung und Elektrode für eine mehrpolige Elektrodenanordnung
US20080193435A1 (en) * 2005-02-24 2008-08-14 Martin Friedlander Revascularization of Ischemic Retinal Tissue and Screening Method Therefor
KR100690802B1 (ko) * 2005-06-10 2007-03-09 엘지전자 주식회사 회동배터리커버를 구비한 이동통신 단말기
CN102105164A (zh) 2008-06-11 2011-06-22 Atyr医药公司 酪氨酰-trna合成酶多肽的血小板生成活性
EP2310498A1 (de) 2008-06-26 2011-04-20 Atyr Pharma, Inc. Glycyl-trna-synthetasen mit nichtkanonischen biologischen aktivitäten umfassende zusammensetzungen und verfahren
ES2552773T3 (es) 2009-02-27 2015-12-02 Atyr Pharma, Inc. Motivos estructurales de polipéptidos asociados con la actividad de señalización celular
JP5730280B2 (ja) 2009-03-16 2015-06-03 パング バイオファーマ リミテッド 非カノニカル生物学的活性を有するヒスチジル−ｔＲＮＡシンテターゼスプライスバリアントを含む組成物および方法
WO2010120509A2 (en) * 2009-03-31 2010-10-21 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
US20110150885A1 (en) * 2009-12-11 2011-06-23 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating hematopoiesis
ES2535951T3 (es) 2009-12-11 2015-05-19 Atyr Pharma, Inc. Histidil ARNt sintetasas para reducir la inflamación
US8828395B2 (en) 2009-12-11 2014-09-09 Atyr Pharma, Inc. Antibodies that bind tyrosyl-tRNA synthetases
CA2797093C (en) 2010-04-26 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
CA2797362C (en) 2010-04-27 2020-12-08 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
CA2797259C (en) 2010-04-27 2020-09-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
WO2011139853A2 (en) 2010-04-28 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
EP2563383B1 (de) 2010-04-29 2017-03-01 Atyr Pharma, Inc. Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von valyl-trna-synthetasen
US8986680B2 (en) 2010-04-29 2015-03-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
CN103140233B (zh) 2010-05-03 2017-04-05 Atyr 医药公司 与甲硫氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
AU2011248357B2 (en) 2010-05-03 2017-02-23 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-tRNA synthetases
CA2797977C (en) 2010-05-03 2019-08-20 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
WO2011139986A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
US9062301B2 (en) 2010-05-04 2015-06-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-tRNA synthetases
EP2566499B1 (de) 2010-05-04 2017-01-25 aTyr Pharma, Inc. Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten aus einem p38-multi-trna-synthetase-komplex
CA2799197C (en) 2010-05-14 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
AU2011258106B2 (en) 2010-05-27 2017-02-23 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
CN103118694B (zh) 2010-06-01 2016-08-03 Atyr医药公司 与赖氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
CA2804278C (en) 2010-07-12 2021-07-13 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
JP6116479B2 (ja) 2010-07-12 2017-04-19 エータイアー ファーマ， インコーポレイテッド グリシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
EP2593126B1 (de) 2010-07-12 2017-09-20 aTyr Pharma, Inc. Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von histidyl-trna-synthetasen
JP5964304B2 (ja) 2010-08-25 2016-08-03 エータイアー ファーマ， インコーポレイテッド チロシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CA2812795C (en) 2010-10-06 2021-08-31 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
US9816084B2 (en) 2011-12-06 2017-11-14 Atyr Pharma, Inc. Aspartyl-tRNA synthetases
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
CN104220461A (zh) 2011-12-29 2014-12-17 Atyr医药公司 天冬氨酰-tRNA合成酶-FC缀合物
EP2814514B1 (de) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen
US20150119792A1 (en) * 2012-05-08 2015-04-30 The Regents Of The University Of California Light degradable drug delivery system for ocular therapy
CN114717206A (zh) 2013-03-15 2022-07-08 Atyr 医药公司 组氨酰-trna合成酶-fc缀合物
ES2821940T3 (es) * 2014-05-19 2021-04-28 Hoffmann La Roche Procedimiento para la producción de polipéptidos
ES2994451T3 (en) 2017-04-20 2025-01-24 Atyr Pharma Inc Compositions for treating lung inflammation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328803B1 (en) 1980-10-20 1994-01-11 Opthalmic Systems, Inc. Opthalmological procedures
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4517295A (en) 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
US5214080A (en) 1987-05-15 1993-05-25 Dainippon Ink And Chemicals, Inc. Process for producing nonaqueous dispersion-type resin
US5282851A (en) 1987-07-07 1994-02-01 Jacob Labarre Jean Intraocular prostheses
US5273751A (en) 1988-03-25 1993-12-28 Seymour Dubroff Composition for preventing clouding of paosterior capsule after extracapsular cataract eye surgery and method of performing cataract surgery
US5229127A (en) 1989-03-03 1993-07-20 Mckinzie James W Rapid miosis with control of intraocular pressure using a mixture of a cetylcholine and carbachol derivatives
US5278126A (en) 1989-03-31 1994-01-11 Ricoh Company, Ltd. Recording process and apparatus and recording medium in the same
US5116868A (en) 1989-05-03 1992-05-26 The Johns Hopkins University Effective ophthalmic irrigation solution
US5292362A (en) 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5273056A (en) 1992-06-12 1993-12-28 Alcon Laboratories, Inc. Use of combinations of viscoelastics during surgery
JP4868681B2 (ja) * 2000-03-31 2012-02-01 ザ スクリプス リサーチ インスティチュート 血管新生の調節のために有用なヒトアミノアシル−ｔＲＮＡシンテターゼポリペプチド

Also Published As

Publication number Publication date
EP2080520A1 (de) 2009-07-22
CN1527719A (zh) 2004-09-08
RU2297425C2 (ru) 2007-04-20
MXPA03007586A (es) 2003-12-11
DE60230860D1 (de) 2009-03-05
JP4448925B2 (ja) 2010-04-14
CA2438273C (en) 2013-06-18
IL157558A (en) 2010-06-16
US20030017564A1 (en) 2003-01-23
NZ528193A (en) 2006-02-24
KR100869914B1 (ko) 2008-11-21
EP1377305B1 (de) 2009-01-14
EP1377305A4 (de) 2005-02-09
CA2438273A1 (en) 2002-09-06
BR0207449A (pt) 2004-04-06
WO2002067970A1 (en) 2002-09-06
ES2318063T3 (es) 2009-05-01
JP2004532010A (ja) 2004-10-21
AU2007219318B2 (en) 2009-12-17
AU2007219318A1 (en) 2007-10-18
RU2003128420A (ru) 2005-02-20
HK1069322A1 (zh) 2005-05-20
JP4361734B2 (ja) 2009-11-11
ZA200307383B (en) 2005-03-30
IL201755A (en) 2015-01-29
EP1377305A1 (de) 2004-01-07
PL208008B1 (pl) 2011-03-31
KR20030078935A (ko) 2003-10-08
CN100486992C (zh) 2009-05-13
JP2009261409A (ja) 2009-11-12
IL157558A0 (en) 2004-03-28
AU2002306558B2 (en) 2007-06-28
PL364596A1 (en) 2004-12-13

Similar Documents

Publication Publication Date Title
DE60230860D1 (de) Von tryptophanyl-trna-synthetase stammende polypeptide zur regulierung der angiogenese
ATE435923T1 (de) Neue polynukleotide und polypeptide des erythropoietingens
IL195812A0 (en) Human tslp dna and polypeptides
DE69926480D1 (de) Acpl dna und polypeptide
AU2003287900A1 (en) Thermostable alpha-amylases
ATE258060T1 (de) Tadg15: eine extrazelluläre serinprotease überexprimiert in brust- und eierstock-karzinomen
DE60142508D1 (de) Menschliche aminoacyl-trna synthetase polypeptide zur regulation der angiogenese
AR096027A2 (es) Proteínas insecticidas quiméricas de bacillus thuringiensis
ATE462006T1 (de) Isoform des vegfs
ATE534742T1 (de) Polypeptide und nukleinsäuren von phorphorymonas gingivalis
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
DE50213015D1 (de) Lipase-varianten
EP1007627A4 (de) Neue extrazelluläre serinprotease
DE60124380D1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
DE69737321D1 (de) Polypeptide der menschlichen hyaluronan-synthase und dafür kodierende dns
ATE428726T1 (de) Xrec2 dns und polypeptide
ATE441865T1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
CA2318490A1 (en) A novel gene for controlling leaf shapes
WO2008104575A3 (en) Immune system mediator
NZ503852A (en) Death associated kinase containing ankyrin repeats (DAKAR)
TH17685B (th) ลำดับเบสของยีนโปรตีนหุ้มห่อของไวรัสโรคใบลายและ?ผิดรูปของมะละกอ
TH21549A (th) ลำดับเบสของยีนโปรตีนหุ้มห่อของไวรัสโรคใบลายและ?ผิดรูปของมะละกอ
WO2007005733A3 (en) Novel peptides promoting neurite outgrowth
DE60117641D1 (de) Modulierte sekretierte alkalische Phosphatase (SEAP) Reporter Gene und Polypeptide
WO2005005466A3 (fr) Sequences nucleiques et proteiques du virus hxhv et utilisations

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties